SPIA
DYN icon

Steward Partners Investment Advisory’s Dyne Therapeutics DYN Stock Holding History

Steward Partners Investment Advisory’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154K Buy
6,944
+64
+0.9% +$1.19K ﹤0.01% 2364
2026
Q1 		$125K Buy
6,880
+2,000
+41% +$34.5K ﹤0.01% 2257
2025
Q4 		$95.5K Buy
4,880
+2,465
+102% +$46.7K ﹤0.01% 2321
2025
Q3 		$30.6K Buy
2,415
+1,065
+79% +$12.1K ﹤0.01% 2884
2025
Q2 		$12.9K Buy
+1,350
New +$14.9K ﹤0.01% 3101
2025
Q1 		– Sell
-610
Closed -$14.4K – 4047
2024
Q4 		$14.4K Buy
610
+235
+63% +$6.95K ﹤0.01% 2942
2024
Q3 		$13.5K Buy
+375
New +$14.9K ﹤0.01% 2833

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Steward Partners Investment Advisory's DYN Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Dyne Therapeutics (DYN) stake by 0.93% in Q2 2026, buying an estimated $1.19K and bringing the position to 6,944 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #2364.

Steward Partners Investment Advisory first reported a position in DYN in Q3 2024 and has held it in 7 quarters since. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Steward Partners Investment Advisory held 6,944 shares of Dyne Therapeutics worth $154K as of Q2 2026.
  • Steward Partners Investment Advisory bought 64 Dyne Therapeutics shares in Q2 2026, an estimated $1.19K.
  • Dyne Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2364 holding.
  • Steward Partners Investment Advisory first reported a position in Dyne Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.